| Product Name | MF | CAS | Details |
|---|
| 4-Chloroaniline-3-sulfonic acid | C6H6ClNO3S | 88-43-7 | Details |
| 3-Phenylbutane-1,2-diamine dihydrochloride | C10H17ClN2 | 1803583-93-8 | Details |
| Af488-azide | C27H26N6O10S2 | 1679326-36-3 | Details |
| Zirconium acetate, in dilute acetic acid, ca. 16% Zr | C2H4O2Zr | 7585-20-8 | Details |
| 2-Vinylnaphthalene | C12H10 | 827-54-3 | Details |
| FAM50B antibody | Details |
| Epidermal Mitosis Inhibiting Pentapeptide | C19H27N5O12 | Details |
| 3-(3,4-dichlorophenyl)propanoic acid | C9H8Cl2O2 | 25173-68-6 | Details |
| KCNMB2 antibody | Details |
| 2-Chloro-5,6-dimethoxy-1,3-benzothiazole | C9H8ClNO2S | 864169-35-7 | Details |
| 2-(Aminomethyl)-3,3-dimethylbutan-1-ol | C7H17NO | 15521-17-2 | Details |
| TCR Alpha + TCR Beta Ab | Details |
| 3-{[(Pyridin-2-yl)methyl]amino}propanenitrile | C9H11N3 | 112086-58-5 | Details |
| 2-Allylphenol | C9H10O | 1745-81-9 | Details |
| rac Xanthoanthrafil-d3 | C19H23N3O6 | 1216710-83-6 | Details |
| 4-(Trifluoromethyl)bicyclo[2.2.2]octan-1-amine hydrochloride | C9H15ClF3N | 22189-91-9 | Details |
| H-STELLIRK^-OH | Details |
| tert-Butyl N-{5-[(azepan-4-yl)amino]pyridin-2-yl}carbamate | C16H26N4O2 | 1699251-73-4 | Details |
| 3-(Trihydroxysilyl)propyloctadecyldimethyl ammonium chloride | C23H52ClNO3Si | 199111-50-7 | Details |
| NSC12 | C24H34F6O3 | 102586-30-1 | Details |
| 7-Amino-2-(pyridin-2-yl)-octahydropyrrolo[1,2-a]piperazin-6-one dihydrochloride | 2241139-46-6 | Details |
| 2'-Methoxybiphenyl-2-carboxylic acid | C14H12O3 | 17296-28-5 | Details |
| Tert-Butyl 7-Bromo-5-Oxa-2-Azaspiro[3.4]Octane-2-Carboxylate | C11H18BrNO3 | 1330765-30-4 | Details |
| 5-(1,3-Dioxolan-2-yl)furan-2-carbonitrile | C8H7NO3 | 1384428-74-3 | Details |
| N-(2-Amino-phenyl)-isonicotinamide | C12H11N3O | 105101-25-5 | Details |
| Semenogelin I antibody | Details |
| cis-(3-amino-1-methyl-cyclobutyl)carbamic acid tert-butyl ester | C10H20N2O2 | 1408076-04-9 | Details |
| Fluphenazine decanoate | C34H48F3N3O2S | 61555-18-8 | Details |
| 2-(4-Chlorophenyl)pyrrolidine hydrochloride | C10H13Cl2N | 1203683-40-2 | Details |
| Proligestone | C24H34O4 | 23873-85-0 | Details |
| tert-Butyl N-(2-amino-2-cyclopropylethyl)carbamate | C10H20N2O2 | 1117693-58-9 | Details |
| 2,6-Dimethyl-beta-cyclodextrin | C56H98O35 | 51166-71-3 | Details |
| 2-(((4-bromophenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione | C15H16BrNO2 | 305864-19-1 | Details |
| 6,6'-Dibromo-2,2'-bipyridine | C10H6Br2N2 | 49669-22-9 | Details |
| Bovine Leptin ELISA kit | Details |
| 1-Amino-2-naphthol-4-sulfonic acid | C10H9NO4S | 116-63-2 | Details |
| HIV-1 tat Protein (1-9) | C43H68N10O17S | 200203-20-9 | Details |
| H-GEGIEEFLR^-OH | Details |
| 1-Deazaadenosine | C11H14N4O4 | 14432-09-8 | Details |
| 1,3-Dimethyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine | C11H16N2 | 1354954-12-3 | Details |
| Prometryn | C10H19N5S | 7287-19-6 | Details |
| C20ORF10 Blocking Peptide | Details |
| 2,3-Dimethyl 7-azabicyclo[2.2.1]heptane-2,3-dicarboxylate | C10H15NO4 | 1393477-05-8 | Details |
| MIA2 Blocking Peptide | Details |
| SLC26A5 antibody | Details |
| 3-(4-Nitrophenyl)propyl bromide | C9H10BrNO2 | 53712-77-9 | Details |
| 2-(1H-1,2,4-Triazol-1-yl)nicotinonitrile | C8H5N5 | 950769-00-3 | Details |
| NX 210 | Details |
| (D-His(Bzl)6)-LHRH (1-7) (free acid) | C53H62N12O11 | 1926163-27-0 | Details |
| 5-Fluoro-3-(4-(4-nitrophenyl)-2-oxobut-3-enylidene)indolin-2-one | C18H11FN2O4 | 1606160-46-6 | Details |
| Methyl 4-methoxyphenylpropionate | C11H14O3 | 15823-04-8 | Details |
| Bullatantriol | C15H28O3 | 99933-32-1 | Details |
| H-TSLFSFR^-OH | Details |
| 2,2,5-Trimethylhex-4-enoic acid | C9H16O2 | 2198-82-5 | Details |
| 4-Mercaptobenzonitrile | C7H5NS | 36801-01-1 | Details |
| 6-Bromo-1-hexene | C6H11Br | 2695-47-8 | Details |
| 5-Methylpyridazine-4-carboxylic Acid | C6H6N2O2 | 1108712-51-1 | Details |
| 6,7,8,9-Tetrahydro-3-[2-[4-(6-hydroxy-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | C23H28N4O3 | 106266-11-9 | Details |
| tert-Butyl 2-carbamothioyl-4-fluoropyrrolidine-1-carboxylate | C10H17FN2O2S | 860344-40-7 | Details |
| 4'-Methoxy-3',beta-dimethyl-beta-nitrostyrene | Details |
| H-HLEINPDHSIIETLR^-OH | Details |
| 2-Chloro-1-[2-(4-fluorophenyl)morpholin-4-yl]ethan-1-one | C12H13ClFNO2 | 1184681-93-3 | Details |
| Recombinant Human PDGF-BB | Details |
| 1-[(tert-Butoxy)carbonyl]-1H,2H,3H-pyrrolo[2,3-b]pyridine-4-carboxylic acid | C13H16N2O4 | 1781907-25-2 | Details |
| (Methanesulfonyloxy)methyl methanesulfonate | C3H8O6S2 | 156-72-9 | Details |
| N-Cyclopropyl-7,8-dimethyl-2,3,4,5-tetrahydro-1-benzoxepin-5-amine | C15H21NO | 1153408-20-8 | Details |
| Laricitrin-3,7,5'-tri-O-glucoside | C34H42O23 | 89345-42-6 | Details |
| 1-(1,3-Dioxaindan-5-yl)-1H-pyrazole-3-carboxylic acid | C11H8N2O4 | 1152534-49-0 | Details |
| PITX2 antibody | Details |
| Methyl (2E)-4-(4-bromophenyl)-4-oxobut-2-enoate | C11H9BrO3 | 32149-27-2 | Details |
| 3-{[4-(1-Hydroxyethyl)phenyl]sulfanyl}azepan-2-one | C14H19NO2S | 1480771-19-4 | Details |
| BL 918 | C23H15F8N3OS | 2101517-69-3 | Details |
| 2-(Oxan-4-yl)butan-1-amine | C9H19NO | 854697-74-8 | Details |
| 1,3-Dimethyl-7-propyl-3,7-dihydro-1H-purine-2,6-dione | C10H14N4O2 | 27760-74-3 | Details |
| 1-Methyl-4-azepanol hydrochloride | C7H16ClNO | 1923194-67-5 | Details |
| 5-[(Oxiran-2-yl)methoxy]-1,3-dioxaindane | C10H10O4 | 38417-65-1 | Details |
| [2-(Methylsulfanyl)phenyl]methanol | C8H10OS | 33384-77-9 | Details |
| (3-Amino-2-benzylpropyl)benzene hydrochloride | C16H20ClN | 890715-21-6 | Details |
| N6-Benzoyl-3'-O-benzoyl-2'-deoxyadenosine | C24H21N5O5 | Details |
| 5,6,7,8-Tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline | C10H11NO2 | 94143-83-6 | Details |
| BIM antibody | Details |
| 2-Amino-5-chloro-pyridine-3-sulfonyl chloride | C5H4Cl2N2O2S | 163137-45-9 | Details |
| 1-(2,4-Dichlorophenyl)butan-2-one | C10H10Cl2O | 94147-69-0 | Details |
| 4-(2-Methoxyethyl)quinoline | C12H13NO | 1309579-41-6 | Details |
| NEFL (284-293) Light | Details |
| LEPREL1 antibody | Details |
| Mahanimbilol | C23H27NO | 77156-13-9 | Details |
| 5-ethyl-3-(trifluoromethyl)-1H-Pyrazole | C6H7F3N2 | 436806-62-1 | Details |
| 5-Methyl-6-oxo-1,6-dihydropyridazine-3-carboxylic acid | C6H6N2O3 | 87668-16-4 | Details |
| {Thieno[2,3-b]pyridin-2-yl}boronic acid | C7H6BNO2S | 953411-01-3 | Details |
| Methyl 2-[3,5-dimethyl-1-(pyridin-2-yl)-1H-pyrazol-4-yl]propanoate | C14H17N3O2 | 1280673-16-6 | Details |
| Rink amide AM resin (200-400 mesh) | Details |
| EPRS Blocking Peptide | Details |
| Methyl 2-(5-amino-4H-1,2,4-triazol-3-yl)acetate | C5H8N4O2 | 875764-86-6 | Details |
| rac-(2R,3R)-2-(1,5-Dimethyl-1H-pyrazol-4-yl)oxolane-3-carboxylic acid | C10H14N2O3 | 1807912-22-6 | Details |
| [6-(Trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methanamine | C8H11F3N4 | 1394116-51-8 | Details |
| (6-((2-(3,4-dimethoxyphenyl)ethyl)amino)-4,4-dimethyl-2-oxocyclohex-1-enyl)-N-benzamide | C25H30N2O4 | 1023883-22-8 | Details |
| 6-a-D-Glucopyranosyl maltotriose | C24H42O21 | 35175-16-7 | Details |
| UBL4B antibody | Details |
| 6-Bromo-[1,2,4]triazolo[1,5-a]pyridine-2-carboxylic acid | C7H4BrN3O2 | 1159811-36-5 | Details |
| Product Total： Product Page： | ||||
| 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 | ||||